Derbyshire Medicines Management and Clinical Policies
Reminder for healthcare professionals that isotretinoin should only be used for severe forms of acne resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy
MHRA October 2023 Isotretinoin (Roaccutaneâ–¼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age.
Patient information leaflet acne ; isotretinoin. NHS website isotretinoin
Further information is available to support the Pregnancy Prevention Programme here
